Rescue of severely affected dystrophin/utrophin deficient mice by morpholino-oligomer mediated exon skipping

被引：0
|
作者：
Goyenvalle, Aurelie [1 ]
Babbs, Arran [1 ]
Powell, Dave [1 ]
Kole, Ryszard [2 ]
Fletcher, Sue [3 ]
Wilton, Steve [3 ]
Davies, Kay [1 ]
机构：
[1] Univ Oxford, Dept Physiol Anat & Genet, MRC, Funct Genom Unit, Oxford OX1 2JD, England
[2] AVI Biopharma, Corvallis, OR USA
[3] Univ Western Australia, Ctr Neuromuscular & Neurol Disorder, Nedlands, WA 6009, Australia
来源：
HUMAN GENE THERAPY | 2009年 / 20卷 / 11期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：1403 / 1403
页数：1
相关论文
共 42 条
  • [31] Antisense-induced Myostatin Exon Skipping Leads to Muscle Hypertrophy in Mice Following Octa-guanidine Morpholino Oligomer Treatment
    Kang, Jagjeet K.
    Malerba, Alberto
    Popplewell, Linda
    Foster, Keith
    Dickson, George
    MOLECULAR THERAPY, 2011, 19 (01) : 159 - 164
  • [32] Human α7 Integrin Gene (ITGA7) Delivered by Adeno-Associated Virus Extends Survival of Severely Affected Dystrophin/Utrophin-Deficient Mice
    Heller, Kristin N.
    Montgomery, Chrystal L.
    Shontz, Kimberly M.
    Clark, K. Reed
    Mendell, Jerry R.
    Rodino-Klapac, Louise R.
    HUMAN GENE THERAPY, 2015, 26 (10) : 647 - 656
  • [33] Current progress with the systemic administration trial of AVI-4658, a novel Phosphorodiamidate Morpholino Oligomer (PMO) skipping dystrophin exon 51 in Duchenne muscular dystrophy (DMD)
    Cirak, S.
    Guglieri, M.
    Shrewsbury, S.
    Bushby, K.
    Muntoni, F.
    NEUROMUSCULAR DISORDERS, 2010, 20 : S5 - S5
  • [34] Tween 85-Modified Low Molecular Weight PEI Enhances Exon-Skipping of Antisense Morpholino Oligomer In Vitro and in mdx Mice
    Wang, Mingxing
    Wu, Bo
    Tucker, Jason D.
    Shah, Sapana N.
    Lu, Peijuan
    Bollinger, Lauren E.
    Lu, Qilong
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2017, 9 : 120 - 131
  • [35] Exon 51 Skipping by Morpholinos Can Restore Dystrophin Expression, Muscle Pathology and Function in Exon 52-Deficient mdx52 Mice
    Aoki, Yoshitsugu
    Yokota, Toshifumi
    Saito, Takashi
    Nakamura, Akinori
    Takeda, Shin'ichi
    MOLECULAR THERAPY, 2009, 17 : S386 - S386
  • [36] A fusion peptide directs enhanced systemic dystrophin exon skipping and functional restoration in dystrophin-deficient mdx mice (vol 18, pg 4405, 2009)
    Yin, HaiFang
    Moulton, Hong M.
    Betts, Corinne
    Seow, Yiqi
    Boutilier, Jordan
    Iverson, Patrick L.
    Wood, Matthew J. A.
    HUMAN MOLECULAR GENETICS, 2019, 28 (04) : 699 - 699
  • [37] Current progress and preliminary results with the systemic administration trial of AVI-4658, a novel phosphorodiamidate morpholino oligomer (PMO) skipping dystrophin exon 51 in Duchenne muscular dystrophy (DMD)
    Shrewsbury, S. B.
    Cirak, S.
    Guglieri, M.
    Bushby, K.
    Muntoni, F.
    NEUROMUSCULAR DISORDERS, 2010, 20 (9-10) : 639 - 640
  • [38] Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study
    Cirak, Sebahattin
    Arechavala-Gomeza, Virginia
    Guglieri, Michela
    Feng, Lucy
    Torelli, Silvia
    Anthony, Karen
    Abbs, Stephen
    Garralda, Maria Elena
    Bourke, John
    Wells, Dominic J.
    Dickson, George
    Wood, Matthew J. A.
    Wilton, Steve D.
    Straub, Volker
    Kole, Ryszard
    Shrewsbury, Stephen B.
    Sewry, Caroline
    Morgan, Jennifer E.
    Bushby, Kate
    Muntoni, Francesco
    LANCET, 2011, 378 (9791): : 595 - 605
  • [39] Cmah-dystrophin deficient mdx mice display an accelerated cardiac phenotype that is improved following peptide-PMO exon skipping treatment
    Betts, Corinne A.
    McClorey, Graham
    Healicon, Richard
    Hammond, Suzan M.
    Manzano, Raquel
    Muses, Sofia
    Ball, Vicky
    Godfrey, Caroline
    Merritt, Thomas M.
    van Westering, Tirsa
    O'Donovan, Liz
    Wells, Kim E.
    Gait, Michael J.
    Wells, Dominic J.
    Tyler, Damian
    Wood, Matthew J.
    HUMAN MOLECULAR GENETICS, 2019, 28 (03) : 396 - 406
  • [40] Rescue of cardiomyopathy through U7snRNA-mediated exon skipping in Mybpc3-targeted knock-in mice
    Gedicke-Hornung, Christina
    Behrens-Gawlik, Verena
    Reischmann, Silke
    Geertz, Birgit
    Stimpel, Doreen
    Weinberger, Florian
    Schlossarek, Saskia
    Precigout, Guillaume
    Braren, Ingke
    Eschenhagen, Thomas
    Mearini, Giulia
    Lorain, Stephanie
    Voit, Thomas
    Dreyfus, Patrick A.
    Garcia, Luis
    Carrier, Lucie
    EMBO MOLECULAR MEDICINE, 2013, 5 (07) : 1128 - 1145
12345